Ro Body vs Found
All-in cost at every dose, fee structure, care model, pharmacy disclosure and terms — compared on one basis.
Only Found publishes a price we could capture ($4,776 for a first year at a maintenance dose). The other does not, so this comparison cannot be settled on cost.
What can be compared is what each discloses: visit model, pharmacy identity, laboratory requirement and cancellation terms. Those are below.
All-in monthly cost = medication + any recurring fee, at a named dose, before tax and before prepaid discounts. Captured 2026-08-05. How we verify a price.
Ro Body vs Found at every dose
A single headline figure assumes a maintenance dose neither you nor your prescriber has chosen yet. This is the same comparison at all six strengths.
Ro Body has left the compounded tirzepatide market. It now carries brand-name products only, with membership billed separately from medication. A price comparison against Found therefore compares two different products under two different regulatory regimes, not two prices for the same thing.
Found still sells a compounded preparation at $398 a month all-in at a 10 mg maintenance dose, about $4,776 for a first year. That is not FDA-approved and is not reviewed by FDA before marketing. The brand route is reviewed and costs more. Which is right for you turns on coverage, not on the headline numbers.
Any comparison you find that still ranks Ro Body for compounded tirzepatide is working from a stale capture. Check the verification date on it.
Ro Body against Found at every dose
| Dose | Ro Body | Found | Cheaper |
|---|---|---|---|
| 2.5 mg | — | $398 | — |
| 5 mg | — | $398 | — |
| 7.5 mg | — | $398 | — |
| 10 mg | — | $398 | — |
| 12.5 mg | — | $398 | — |
| 15 mg | — | $398 | — |
What differs beyond price
Price is the easiest thing to compare and rarely the thing that decides satisfaction. These are the attributes each programme publishes.
| Attribute | Ro Body | Found |
|---|---|---|
| Pricing model | model unknown | flat at every dose |
| Membership | $145/mo | $99/mo |
| Prepaid rate | none published | $169 |
| Visit model | async + messaging | async |
| Labs | optional | optional |
| Pharmacy disclosure | brand fulfilment | not named |
| Cancellation | membership recurring | membership recurring |
| Regulatory status | compounded, not FDA-approved | compounded, not FDA-approved |
| Evidence status | no price published | third-party figure |
Which one, for whom
If you want the lowest total cost: neither can be ranked on cost until both publish a price.
If you want budget certainty: Found, which holds one price at every strength.
If you want to verify the supply chain: Ro Body, which names its dispensing pharmacy.
If you may need to stop early: compare the cancellation rows above before prepaying. Compounded medication is generally not refundable once it has shipped, so a multi-month term is the wrong structure during titration, when intolerance is the most likely reason to stop.
Switching between them
Usually possible after a clinical review, and the two real risks are a supply gap while a new intake is processed and a new prescriber restarting titration rather than continuing your dose. Confirm dose continuity in writing before cancelling anything, because a month back at 2.5 mg is a month of lost progress no price difference recovers.
Fee structure, side by side
Ro Body charges a mandatory membership of $145 a month on top of medication. Found charges a mandatory membership of $99 a month.
This is where most published comparisons break. A table quoting medication alone understates a membership programme by the full fee, every month, for as long as you stay. Every figure here folds it in, which is why our number can be higher than the one on a programme's own homepage.
Care model and what it buys
Ro Body: async + messaging, labs optional, insurance concierge. Found: async, labs optional, behaviour programme.
Video visits, included laboratory work and real clinician access cost money to provide, and programmes providing them are rarely cheapest. That is what you are paying for. The failure is paying a premium for an asynchronous questionnaire a cheaper programme provides identically.
Verification, which outranks both
Ro Body: brand fulfilment. Found: not named.
A programme that will not name the pharmacy compounding your medicine is asking you to inject an unidentified preparation weekly. State boards publish licensee registers and FDA publishes outsourcing-facility registrations and warning letters, all free and searchable — but only if you have a name. That question outranks a price difference of almost any size.
What can still be decided here
Without a price on both sides this cannot be settled on cost, so it has to be settled on everything else — and everything else is frequently the better basis anyway.
Ro Body publishes: visit model async + messaging, laboratory requirement optional, pharmacy brand fulfilment, cancellation membership recurring. Found publishes: visit model async, laboratory requirement optional, pharmacy not named, cancellation membership recurring.
A programme that publishes four of those and one that publishes none are not equally knowable, and that asymmetry is a finding rather than a gap in our research. Ask both for the total at 10 mg including every fee, in writing, and see which answers.
Where ro body and found sits in the decision
Most people arrive at this market with one question — what is cheapest — and leave with a worse one, because cheapest depends on a dose nobody has chosen yet and a fee structure that is not in the advertisement.
6 of the 17 priced programmes charge a mandatory recurring fee on top of medication. 11 hold one price at every strength; the rest reprice as you climb. Those two facts reorder any ranking built on headline figures, and neither is visible without reading the terms.
The four disclosures worth insisting on
Price at the dose you will hold. The identity of the dispensing pharmacy. Whether the quoted rate survives renewal. And what is refundable before shipment.
Only 3 of 17 priced programmes publish the second, which is the one that lets you check a public state board register before injecting anything weekly. It costs a programme nothing to publish and its absence is the most reliable signal in this market.
Turning this into an email
Everything above converts into questions a programme can answer in two minutes. Anything that cannot is context rather than a check, and context does not protect you.
Send them before paying. Almost every dispute that appears in public complaint records for this category traces to a number that was never put in writing, and the programmes that reply promptly and specifically are rarely the ones patients later write about.
Why this comparison cannot be settled on price
Only Found publishes a price we could capture, at about $4,776 for a first year at a maintenance dose. The other does not. A comparison that filled that gap with an estimate would be inventing the only number that matters.
What can be compared is what each discloses before you pay, and that is frequently the more useful comparison anyway. A programme that names its pharmacy, states its cancellation terms and publishes a price at every dose has told you how it will behave when something goes wrong.
What to do instead
Ask both for the total at 10 mg including every fee, in writing, and compare the replies against the programmes that already publish. If one answers in a sentence and the other does not answer at all, you have your comparison.
Why we publish the page anyway
Because the absence is the finding. Someone searching for this pairing deserves to know that one side cannot be priced, rather than being shown a fabricated number or no page at all.
Fee structure, side by side
Ro Body charges a mandatory membership of $145 a month on top of medication. Found charges a mandatory membership of $99 a month.
This is where most published comparisons break. A table quoting medication alone understates a membership programme by the full fee, every month, for as long as you stay. Every figure here folds it in, which is why our number can be higher than the one on a programme's own homepage.
Care model and what it buys
Ro Body: async + messaging, labs optional, insurance concierge. Found: async, labs optional, behaviour programme.
Video visits, included laboratory work and real clinician access cost money to provide, and programmes providing them are rarely cheapest. That is what you are paying for. The failure is paying a premium for an asynchronous questionnaire a cheaper programme provides identically.
Verification, which outranks both
Ro Body: brand fulfilment. Found: not named.
A programme that will not name the pharmacy compounding your medicine is asking you to inject an unidentified preparation weekly. State boards publish licensee registers and FDA publishes outsourcing-facility registrations and warning letters, all free and searchable — but only if you have a name. That question outranks a price difference of almost any size.
What can still be decided here
Without a price on both sides this cannot be settled on cost, so it has to be settled on everything else — and everything else is frequently the better basis anyway.
Ro Body publishes: visit model async + messaging, laboratory requirement optional, pharmacy brand fulfilment, cancellation membership recurring. Found publishes: visit model async, laboratory requirement optional, pharmacy not named, cancellation membership recurring.
A programme that publishes four of those and one that publishes none are not equally knowable, and that asymmetry is a finding rather than a gap in our research. Ask both for the total at 10 mg including every fee, in writing, and see which answers.
Where ro body and found sits in the decision
Most people arrive at this market with one question — what is cheapest — and leave with a worse one, because cheapest depends on a dose nobody has chosen yet and a fee structure that is not in the advertisement.
6 of the 17 priced programmes charge a mandatory recurring fee on top of medication. 11 hold one price at every strength; the rest reprice as you climb. Those two facts reorder any ranking built on headline figures, and neither is visible without reading the terms.
The four disclosures worth insisting on
Price at the dose you will hold. The identity of the dispensing pharmacy. Whether the quoted rate survives renewal. And what is refundable before shipment.
Only 3 of 17 priced programmes publish the second, which is the one that lets you check a public state board register before injecting anything weekly. It costs a programme nothing to publish and its absence is the most reliable signal in this market.
Turning this into an email
Everything above converts into questions a programme can answer in two minutes. Anything that cannot is context rather than a check, and context does not protect you.
Send them before paying. Almost every dispute that appears in public complaint records for this category traces to a number that was never put in writing, and the programmes that reply promptly and specifically are rarely the ones patients later write about.
Open these rather than taking our word for it. Every one is a regulator, a trial registry, a label, an accreditor or the manufacturer.
Compare every programme on one screen
The matrix carries all-in price at every dose, fee structure, commitment terms, pharmacy disclosure and verification status for every programme we track.
Common questions
Is Ro Body or Found cheaper?
Only one of the two publishes a price we could capture, so this comparison cannot be settled on cost. Both are compared on terms and disclosure instead.
Do Ro Body and Found charge a membership on top of medication?
Ro Body: yes, $145 a month. Found: yes, $99 a month. Every figure on this page includes it where charged.
Does Ro Body or Found name its dispensing pharmacy?
Ro Body: brand fulfilment. Found: not named. It is the disclosure that lets you check a state board register before you inject anything weekly.
Can I switch between them mid-treatment?
Usually yes, after a clinical review. Confirm dose continuity in writing and do not cancel the old programme until the new one has shipped, because a supply gap costs more than a price difference.
Is either Ro Body or Found FDA-approved?
Compounded preparations are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality before marketing. Where a programme supplies brand product, that product is approved; the programme around it is not a regulated entity in the same sense.